TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shilpa Medicare Limited ( (IN:SHILPAMED) ) just unveiled an announcement.
Shilpa Medicare Limited has announced that it will release its second-quarter earnings results for the fiscal year 2026 on November 13, 2025, with an earnings call scheduled for November 17, 2025. This announcement is significant as it provides stakeholders with insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.
More about Shilpa Medicare Limited
Shilpa Medicare Limited is an integrated pharmaceutical group specializing in niche Oncology and Non-oncology APIs, Peptides, Polymers, and differentiated finished dosage formulations such as orally dispersible films and transdermal patches. The company also offers comprehensive CDMO services to global pharmaceutical firms, leveraging its robust R&D and manufacturing capabilities, supported by four R&D units and seven manufacturing facilities.
Average Trading Volume: 26,593
Technical Sentiment Signal: Buy
Current Market Cap: 70.06B INR
Learn more about SHILPAMED stock on TipRanks’ Stock Analysis page.